Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Moving to Electronic Prior Authorization Requires Incremental Steps

March 18th 2020

In a time of tremendous technological advancement, how is it that 90% of communications between providers and payers for prior authorizations are still done by phone or fax, and how do we move to more automated processes?1

Cancer Registry Launches to Inform COVID19+ Patient Demographics

March 18th 2020

Jeremy L. Warner, MD, MS, discusses the goals of the COVID-19 and Cancer Consortium Registry, what other data need to be extrapolated with COVID-19, and how the virus could impact patients with cancer.

Dr. Campbell on Precautions for Preventing Spread of COVID-19

March 18th 2020

Matthew T. Campbell, MD, MS, shares ways to prevent the spread of coronavirus 2019.

Dr. Bardia on the Potential Impact of COVID-19 on Immunocompromised Patients

March 18th 2020

Aditya Bardia, MD, MPH, discusses the potential impact of novel coronavirus on immunocompromised patients.

Automated Prior Authorization Catches On

March 17th 2020

In January, America’s Health Insurance Plans in collaboration with payers representing 60 million covered individuals launched the Fast Prior Authorization Technology Highway to improve the prior authorization process.

The Future Direction of Biosimilars

March 16th 2020

The Availability of Multiple Biosimilars for 1 Biologic

March 16th 2020

Educating Physicians When Prescribing Biosimilars

March 16th 2020

Pharmacovigilance Requirements for Biosimilar Products

March 16th 2020

Biosimilar Interchangeability in Practice

March 16th 2020

Evidence-Based Extrapolation for Biosimilars

March 16th 2020

The Complexity of Choosing Biosimilars in Oncology

March 16th 2020

The Use of Biosimilars in HER2+ Breast Cancer

March 16th 2020

Biosimilar Use in the Treatment of NSCLC

March 16th 2020

Decision Makers for Formulary Approval of Biosimilars

March 16th 2020

The Adoption and Choice of Biosimilars

March 16th 2020

An Overview of Biosimilarity

March 16th 2020

Vaccines Show Promise and Pitfalls of Public Health Strategies

March 13th 2020

Segments of the population have apparently rejected the well-documented clinical utility of vaccination for protecting individual and public health. An immediate specific concern is the contentious matter of measles vaccination, which has been well-reported in the lay press.

Oncology Fellows: Reminding Ourselves of How Far We've Come

March 12th 2020

For us, a group of 15 black students at Tulane University School of Medicine (TUSCOM), a visit to the Whitney Plantation in Edgard, Louisiana, was a no-brainer. The process of navigating medical school is pure hell at times, and you need inspiration wherever and whenever you can get it.

Coronavirus: What Oncologists Are Telling Their Patients

March 9th 2020

Patient concern about coronavirus 2019 varies by oncology clinic according to the OncologyLive® advisory board members, who discussed in a recent interview how COVID-19 has guided their patient interactions and what steps they are advising patients to take to protect themselves.